Zobowiązania Zmiana Data
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Adma Biologics USD 95.28M 19.52M 2026-09
ALKERMES USD 651.93M 10.16M 2026-09
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
AstraZeneca USD 31.27B 286M 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Cipla INR 69.77B 366.6M 2026-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.63M 596K 2026-06
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 47B 745M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
J&J USD 55.46B 562M 2026-09
Merck USD 28.8B 1.07B 2026-09
Minerva Neurosciences USD 2.29M 381K 2025-12
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Novavax USD 329.84M 729K 2026-09
Pfizer USD 31.73B 920M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Takeda JPY 2.6T 161B 2026-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12